Navigation Links
Pharmatek Laboratories Announces Acquisition of the First Xcelodose(R) 600S System on the West Coast
Date:10/2/2009

SAN DIEGO, Oct. 2 /PRNewswire/ -- Pharmatek Laboratories, Inc., a premier contract development and manufacturing organization supporting the pharmaceutical industry, announced that it is the first CRO on the West Coast to acquire the Xcelodose system, enhancing the company's preclinical and early phase clinical GMP supply capabilities.

"Pharmatek is always looking for ways to move our customers' drug candidates into the clinic more efficiently without compromising quality," said Jeffrey Bibbs, Ph.D., Chief Scientific Officer of Pharmatek Laboratories. "For powder-in-capsule (PIC) applications, the Xcelodose can drastically decrease time to clinic while also lowering the cost of drug product for first-in-human trials."

The Xcelodose, manufactured by Capsugel, a division of Pfizer, is a precision powder micro-doser and automated encapsulator that has the ability to fill formulations or active pharmaceutical ingredient (API) directly into capsules with a remarkable level of accuracy. The Xcelodose can measure to levels as low as 100 micrograms and can dispense into capsules from size 00 to 4. Dosing directly into capsules can reduce the amount of API required. Additionally, the unit reduces overall development time by simplifying analytical and stability protocols.

Pharmatek Laboratories will install the Xcelodose unit in its solid dose manufacturing facility located in San Diego, California. The unit is expected to be validated by mid-October 2009. The company is currently scheduling Xcelodose manufacturing productions for November and December, 2009.

About Pharmatek Laboratories, Inc.

Pharmatek Laboratories, Inc. is a premier pharmaceutical chemistry development company providing full-service pharmaceutical chemistry product development for the pharmaceutical industry. Pharmatek focuses on bringing client compounds from discovery to the clinic with services that include compound selection, analy
'/>"/>

SOURCE Pharmatek Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Pharmateks Highly-Potent and Cytotoxic (HP/C) Facility Positions It as Industry Leader in Development and Manufacturing of HP/C Compounds
2. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
3. Forest Laboratories, Inc. and Gedeon Richter Announce Results of Phase II-B Study for RGH-188 as a Treatment for Schizophrenia
4. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
5. Romark Laboratories Raises $18 Million in Institutional Financing
6. Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2b Studies
7. Romark Laboratories Initiates Phase II Study of Nitazoxanide in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1
8. Northfield Laboratories Inc. Presentation at FDA/NIH Workshop on Hemoglobin-Based Oxygen Carriers
9. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
10. Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders
11. Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: ... 2010 the U.S. Food and Drug Administration,s ... the New Drug Application (NDA) for pixantrone ... lymphoma (NHL). ODAC is an independent panel ... efficacy and safety of marketed and investigational ...
(Date:12/16/2009)... Today, a group of national medical societies ... 3590, the Patient Protection and Affordable Care Act, currently ... way towards a final vote in the coming days. ... to vote against a health care bill that is ... hand that our health care system needs reform - ...
(Date:12/16/2009)... , Dec. 16 MedSolutions ( ... management services, today commended two new studies highlighting ... scans and other diagnostic imaging tests. ,, ... proper diagnosis and treatment," said Gregg Allen, M.D., ... studies offer more compelling evidence that stricter quality ...
Breaking Medicine Technology:Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 2Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 3Cell Therapeutics Announces FDA's Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma, February 10, 2010 4Physician Groups Oppose Current Senate Health Care Reform Bill 2MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure 2MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure 3PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies 4671 1PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies 4671 2Pennsylvania Department of Health Workshops Will Help Businesses Prepare for Flu Pandemic 50436 1Pennsylvania Department of Health Workshops Will Help Businesses Prepare for Flu Pandemic 50436 2Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain 12852 1Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain 12852 2Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain 12852 3Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain 12852 4Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain 12852 5
(Date:12/16/2009)... 17 If proposed health care legislation ... the employer-based insurance system. Approximately 18.4 million Californians ... 65 rely upon employer-based insurance for their health ... versions of reform legislation entail specific requirements for ... employees work for firms that currently comply with ...
(Date:12/16/2009)... -- Health care sector revenue increased by 5.7 ... $1.66 trillion in 2007, according to new data ... classified under the North American Industry Classification System ... ,, These figures come from the 2008 ... , a series of tables which provides estimates ...
(Date:12/16/2009)... Texas, Dec. 16 Austin,s Custom Tops ... countertops, co-sponsored, with Ryan Gray and Hill Country Home ... West on Wednesday, December 9th. Fifty people showed up ... their way through platefuls of sliders in support of ... What started as a casual bet over who could ...
(Date:12/16/2009)... -- Smart Balance, Inc. (Nasdaq: SMBL ) announced ... two-year stock repurchase program of up to $25 million, ... the confidence we have in the prospects of our ... for all of our shareholders, while at the same ... Smart Balance, Inc. Chairman and Chief Executive Officer. ,, ...
(Date:12/16/2009)... to Benefit of Children with Autism and Other Special ... and Zachary Levi Join Ben Stiller to Ring in ... At its 13th annual Teddy Bear Ball, ... President & CEO Brian Goldner received ... his far-reaching philanthropic leadership and commitment to children,s causes; ...
Breaking Medicine News(10 mins):Health News:How National Health Reform Proposals Would Affect Employer-Based Plans in California 2Health News:How National Health Reform Proposals Would Affect Employer-Based Plans in California 3Health News:Census Bureau: Health Care Industries Showed Modest Growth in Revenue in 2008 2Health News:Census Bureau: Health Care Industries Showed Modest Growth in Revenue in 2008 3Health News:Austin-Based Business Co-Sponsors Gastric Feat for Charity 2Health News:Smart Balance Authorizes Stock Repurchase Program 2Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 2Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 3Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 4Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 5
... could not only make you loose your sight but even your ... the eye may have to be removed. ,Researchers at the ... plasma to shoot tiny bullets of blockage-dissolving drugs into a ... the retina drain into a single vein. "If this central vein ...
... Complication as its other name. Among the many complications that ... ulcer, as damage can be severe enough to require amputation. ... in disguise would be a new device that delivers a ... stimulation would help in the healing of foot ulcers. ...
... basis. One of these latest laser techniques is helpful in ... This degenerative condition cause blood vessels to grow underneath the ... ,Eye specialists have come up with a new therapy ... of damaging the retinal tissue. ,This is a two-step ...
... to strike a pot of gold by making cheap ... is likely to escalate in coming days. ,The ... to develop anti-AIDS drugs and market it in India ... ,The anti-AIDS drug market, currently dominated by Mumbai-based Cipla, ...
... of Bihar were facing the worst forms of nightmare over ... political scenario but the threat of malaria . ,Malaria ... invaded the tribal areas of Munger, 200 km (125 miles) ... died of cerebral malaria in this eastern Indian state of ...
... of the American Journal of Epidemology, moderate levels of ... According to Dr. Susanne Hoidrup from Glostrup University Hospital, ... process, regular physical activity should become an essential part ... increase in hip fractures. ,In the study, ...
Other Medicine News:Health News:Blocked viens block eye sight 2
For use with catalog #0454....
Determination of FDP in Plasma by Latex Agglutination, 60 tests.Microlatex particles coated with mouse monoclonal anti-human FDP antibodies....
Lupus Anticoagulant-Sensitive APTT Reagent.Cephalin with particulate activator (silica), freeze-dried....
Detection of Lupus Anticoagulants. Freeze-dried hexagonal phase phos-phatidylethanolamine; normal plasmawith heparin inhibitor; PTT-LS reagent of cephalin and particulate siliceous activator;all free...
Medicine Products: